BRIVLERA 10 MG
BRIVARACETAM : 10 MG · DIN 02452995 · UCB CANADA INC
Health Canada status: MARKETED
What is BRIVLERA?
BRIVLERA 10 MG contains BRIVARACETAM : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02452995, held by UCB CANADA INC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 10-Oct-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is BRIVLERA used for?
BRIVLERA (brivaracetam) is indicated as adjunctive therapy in the management of partial-onset seizures in patients 4 years of age and older with epilepsy who are not satisfactorily controlled with conventional therapy. BRIVLERA (brivaracetam) solution for injection for intravenous use is an alternative for adults when oral administration is temporarily not feasible.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02452995 |
|---|---|
| Brand name | BRIVLERA |
| Generic / active ingredient | BRIVARACETAM : 10 MG |
| Manufacturer | UCB CANADA INC |
| Strength | 10 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | N03AX23 BRIVARACETAM |
| AHFS class | 38:00.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 10-Oct-2018 |
| Original market date | 2018-11-19 00:00:00 |
How is it stored and handled?
null
How is it supplied?
BRIVLERA tablets are supplied in white HDPE bottles of 60 tablets, PVC/PCTFE - Aluminium single unit dose blisters. BRIVLERA (brivaracetam) oral solution 10 mg/mL is supplied in 300 mL amber glass bottles. BRIVLERA (brivaracetam) solution for injection 10 mg/mL is supplied in 6 mL colourless single-use glass vials. Each vial contains 5 mL of brivaracetam solution for injection.
What can be used instead?
Other Canadian products sharing ATC code N03AX23 BRIVARACETAM. 14 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-BRIVARACETAM | 10 MG | TABLET | APOTEX INC | MARKETED | DIN 02538679 |
| APO-BRIVARACETAM | 100 MG | TABLET | APOTEX INC | MARKETED | DIN 02538717 |
| APO-BRIVARACETAM | 25 MG | TABLET | APOTEX INC | MARKETED | DIN 02538687 |
| APO-BRIVARACETAM | 50 MG | TABLET | APOTEX INC | MARKETED | DIN 02538695 |
| APO-BRIVARACETAM | 75 MG | TABLET | APOTEX INC | MARKETED | DIN 02538709 |
| AURO-BRIVARACETAM | 100 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02539306 |
| AURO-BRIVARACETAM | 50 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02539292 |
| BRIVLERA | 10 MG | TABLET | UCB CANADA INC | MARKETED | DIN 02452936 |
| BRIVLERA | 10 MG | SOLUTION | UCB CANADA INC | MARKETED | DIN 02452987 |
| BRIVLERA | 100 MG | TABLET | UCB CANADA INC | MARKETED | DIN 02452979 |
Who else supplies BRIVARACETAM worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BRIVARACETAM appears in 106 registered pack listings across 10 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.